APA Цитирование

Zhuang, X., Zhao, C., Li, J., Su, C., Chen, X., Ren, S., . . . Zhou, C. (2019). Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF. Cancer Med.

Chicago-стиль цитирования

Zhuang, Xibin, Chao Zhao, Jiayu Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Xuefei Li, and Caicun Zhou. "Clinical Features and Therapeutic Options in Non‐small Cell Lung Cancer Patients With Concomitant Mutations of EGFR, ALK, ROS1, KRAS or BRAF." Cancer Med 2019.

MLA-цитирование

Zhuang, Xibin, et al. "Clinical Features and Therapeutic Options in Non‐small Cell Lung Cancer Patients With Concomitant Mutations of EGFR, ALK, ROS1, KRAS or BRAF." Cancer Med 2019.

Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.